To study the oral effect of jyotishmati vati in patient of Artavkshaya

A Randomized Open Labelled Controlled Clinical Trial To Assess An Effect Of Durva Swarasa Bhavit Jyotishmati Vati In Artavkshaya With Special Reference To Oligomenorrhea - Nil

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/092960

Enrollment

Registered

2025-08-13

Start date

Unknown

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N915- Oligomenorrhea, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Selection irrespective of marital status, parity, socioeconomic status Patients with sign and symptoms of Oligomenorrhea Quantity of bleeding less than 80 mL Hb should be greater than 8 gm% BMI should be between 19 to 30

Exclusion criteria

Exclusion criteria: Known patients of blood dyscrasias. Known patients of major systemic diseases that are likely to influence menstrual rhythm. For e.g.; HTN, DM, TB, HIV, Thyroid, Nephrotic disorders. Known patients of malignancy, cervical erosion, polyp, endometriosis, tubo- ovarian mass and PCOS/PCOD. Known case of structural anomalies of genital organs. Patients using IUCD s. Post Ligation Syndrome Patients Patients who recently undergone Dilatation and Curettage Surgery. Patients undergoing treatment for any other serious illness.

Design outcomes

Primary

Measure	Time frame
To study the efficacy of durva swaras bhavit jyotishmati vati in Artavkshaya with special reference to oligomenorrheaTimepoint: 3 months	—

Secondary

Measure	Time frame
To study detail about Artavkshaya To study properties of durva swaras bhavit jyotishmati vatiTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Bhagyashri Mahavir Khot

R.A Podar Ayurved College

khotbhagyashri@gmail.com9850539489

Outcome results